Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cells

导出原文传递

翻译打印收藏纠错

作者： Chang,D.-K. ^[1] ; Sui,J. ^[2] ; Geng,S. ; Muvaffak,A. ; Bai,M. ; Fuhlbrigge,R.C. ; Lo,A. ; Yammanuru,A. ; Hubbard,L. ; Sheehan,J. ; Campbell,J.J. ; Zhu,Q. ; Kupper,T.S. ; Marasco,W.A.

作者单位： Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United ^[1] Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School ^[2]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Molecular cancer therapeutics

2012年11卷11期

2451-2461页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cells

Molecular cancer therapeutics

相似文献

Molecular cancer therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cells

Molecular cancer therapeutics

相似文献

Molecular cancer therapeutics

相关期刊

检索历史清除